Related Experiment Videos
Elective orthopaedic surgery for inhibitor patients
E C Rodriguez-Merchan1, J D Wiedel, T Wallny
1Service of Traumatology and Orthopaedic Surgery, and Haemophilic Center, La Paz University Hospital, Madrid, Spain. rmerchan@arrakis.es
Haemophilia : the Official Journal of the World Federation of Hemophilia
|September 27, 2003
Summary
Elective orthopaedic surgery (EOS) is now a viable option for haemophilic patients with inhibitors, offering improved quality of life. Careful case analysis and multidisciplinary teams ensure successful outcomes for these complex procedures.
Area of Science:
- Orthopaedic Surgery
- Haematology
- Patient Outcomes
Background:
- Haemophilic patients with inhibitors present unique challenges for elective orthopaedic surgery (EOS).
- Previous surgical interventions in this population were often associated with high risks and limited success rates.
Purpose of the Study:
- To evaluate the safety and efficacy of EOS in haemophilic patients with inhibitors.
- To assess the outcomes of radiosynoviortheses and major orthopaedic procedures in this cohort.
Main Methods:
- A retrospective analysis of 108 elective orthopaedic procedures (88 radiosynoviortheses, 20 major surgeries) across nine international centers.
- Patient data, including age, follow-up duration, procedure type, and outcomes, were collected and analyzed.
- Complication rates, particularly bleeding events, were meticulously recorded and assessed.
Main Results:
- Overall, 82 out of 108 procedures resulted in good outcomes.
- Radiosynoviortheses showed a high success rate with no reported complications.
- Major orthopaedic procedures had a 15% complication rate (bleeding), linked to insufficient recombinant activated factor VII dosage.
Conclusions:
- Elective orthopaedic surgery is feasible and successful in haemophilic patients with inhibitors.
- A multidisciplinary approach and thorough case evaluation are crucial for optimizing surgical outcomes.
- EOS can significantly enhance the quality of life for haemophilic patients with inhibitors.